Johannes Fruehauf, MD, has dedicated much of his professional endeavors to supporting life science entrepreneurship through his work as both a physician and a biotech entrepreneur. He is currently general partner and co-founder of Mission BioCapital, where he sources, diligences, and leads new life science investment transactions and represents the fund on the boards of several portfolio companies. Johannes is also the founder and president of LabCentral and BioLabs, the largest provider of laboratory co-working space for startups nationwide, currently serving more than 300 startups which, as of 2019, account for more than 20 percent of all Seed and Series A venture capital invested in life sciences in the US.

After receiving his doctorate from the University of Heidelberg, Johannes practiced medicine (internal medicine and OB/Gyn) for several years in Germany before coming to Boston for post-doctoral training at Beth Israel Deaconess Medical Center/Harvard Medical School. He is the author of more than 30 peer reviewed publications and is named inventor on nine issued patents on drug delivery and RNAi-based therapeutics.